(1491701-03) Emerging Therapies of Interstitial Lung Disease in Acute Settings

Location: Congress Digital

Bonus CE Session Faculty(s)

HK

Hyun Kim

University Of Minnesota
Minneapolis

Disclosure(s):

Hyun Kim: Boehringer Ingelheim: Clinical Trial Investigator (Ongoing); fibrogen: Clinical Trial Investigator (Terminated); Genenetech: Clinical Trial Investigator (Terminated); nitto denko: Clinical Trial Investigator (Terminated); United Therapeutics: Clinical Trial Investigator (Ongoing)

Discussion of AE-ILD prognosis and new therapies on the horizon for AE-ILD patients including recent clinical trials